Rafael Daltro De Oliveira

Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission

W. Vainchenker, C. Chomienne, E. Raffoux, 2020 .

SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN)

W. Vainchenker, E. Raffoux, C. Dosquet, 2020 .